急性冠脉综合征合并慢性肾脏病退伍军人中临床指征性侵入性心脏诊疗的使用与结局
该回顾性队列研究纳入2013年1月至2017年12月在美国退伍军人事务医疗中心住院并出院诊断为急性冠脉综合征的退伍军人。在34,430例有临床指征行侵入性诊疗的患者中,合并慢性肾脏病者较未合并者更少接受此类诊疗(校正比值比0.68,95%置信区间0.65至0.72)。在慢性肾脏病患者中,未接受侵入性诊疗与6个月全因死亡风险升高相关(校正风险比1.39,95%置信区间1.29至1.49)。
要点
- 在34,430例有临床指征行侵入性诊疗的急性冠脉综合征退伍军人中,合并慢性肾脏病者较未合并者更少接受此类诊疗(校正比值比0.68,95%置信区间0.65至0.72)。
- 在慢性肾脏病患者中,未接受侵入性诊疗与6个月全因死亡风险升高相关(校正风险比1.39,95%置信区间1.29至1.49)。
- 慢性肾脏病患者中未接受侵入性诊疗的6个月全因死亡绝对风险为21.5%,接受者为15.5%,绝对风险差6.0%。
核心结论
- 在当前实践中,合并慢性肾脏病的急性冠脉综合征退伍军人较未合并者更少接受临床指征性侵入性心脏诊疗。
- 未接受此类诊疗与死亡风险升高相关。
研究设计与样本
- 回顾性队列研究,纳入2013年1月至2017年12月在美国退伍军人事务医疗中心住院并出院诊断为急性冠脉综合征的退伍军人。
- 采用多变量逻辑回归分析慢性肾脏病与基于全球急性冠脉事件注册2.0风险评分判定为临床指征(6个月预测全因死亡率≥5%)的侵入性诊疗使用之间的关联。
- 采用倾向评分和逆概率加权分析未接受临床指征性侵入性诊疗与6个月全因死亡之间的关联。
主要发现
- 在34,430例有临床指征行侵入性诊疗的患者中,合并慢性肾脏病的18,780例较未合并慢性肾脏病的15,650例更少接受此类诊疗(校正比值比0.68,95%置信区间0.65至0.72)。
- 在慢性肾脏病患者中,未接受侵入性诊疗与6个月全因死亡风险升高相关(绝对风险21.5%对15.5%;绝对风险差6.0%;校正风险比1.39,95%置信区间1.29至1.49)。
- 多项敏感性分析结果一致。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
SIGNIFICANCE STATEMENT: Of studies reporting an association of CKD with lower use of invasive cardiac care to treat acute coronary syndrome (ACS), just one accounted for the appropriateness of such care. However, its findings in patients hospitalized nearly 30 years ago may not apply to current practice. In a more recent cohort of 64,695 veterans hospitalized with ACS, CKD was associated with a 32% lower likelihood of receiving invasive care determined to be clinically indicated. Among patients with CKD, not receiving such care was associated with a 1.39-fold higher risk of 6-month mortality. Efforts to elucidate the reasons for this disparity in invasive care in patients with ACS and CKD and implement tailored interventions to enhance its use in this population may offer the potential to improve clinical outcomes. BACKGROUND: Previous studies have shown that patients with CKD are less likely than those without CKD to receive invasive care to treat acute coronary syndrome (ACS). However, few studies have accounted for whether such care was clinically indicated or assessed whether nonuse of such care was associated with adverse health outcomes. METHODS: We conducted a retrospective cohort study of US veterans who were hospitalized at Veterans Affairs Medical Centers from January 2013 through December 2017 and received a discharge diagnosis of ACS. We used multivariable logistic regression to investigate the association of CKD with use of invasive care (coronary angiography, with or without revascularization; coronary artery bypass graft surgery; or both) deemed clinically indicated based on Global Registry of Acute Coronary Events 2.0 risk scores that denoted a 6-month predicted all-cause mortality ≥5%. Using propensity scoring and inverse probability weighting, we examined the association of nonuse of clinically indicated invasive care with 6-month all-cause mortality. RESULTS: Among 34,430 patients with a clinical indication for invasive care, the 18,780 patients with CKD were less likely than the 15,650 without CKD to receive such care (adjusted odds ratio, 0.68; 95% confidence interval, 0.65 to 0.72). Among patients with CKD, nonuse of invasive care was associated with higher risk of 6-month all-cause mortality (absolute risk, 21.5% versus 15.5%; absolute risk difference 6.0%; adjusted risk ratio, 1.39; 95% confidence interval, 1.29 to 1.49). Findings were consistent across multiple sensitivity analyses. CONCLUSIONS: In contemporary practice, veterans with CKD who experience ACS are less likely than those without CKD to receive clinically indicated invasive cardiac care. Nonuse of such care is associated with increased mortality.
引用
- Weisbord SD, Mor MK, Hochheiser H, et al. Utilization and Outcomes of Clinically Indicated Invasive Cardiac Care in Veterans with Acute Coronary Syndrome and Chronic Kidney Disease. J Am Soc Nephrol. 2023. PMID: 36735537. doi:10.1681/ASN.0000000000000067
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。